These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 6663745)
1. [Therapy of Kawasaki disease in the acute phase: steroid and aspirin therapy]. Kato H; Ichinose E Nihon Rinsho; 1983 Sep; 41(9):2092-6. PubMed ID: 6663745 [No Abstract] [Full Text] [Related]
2. Efficacies and risks of aspirin in the treatment of the Kawasaki disease. Kusakawa S; Tatara K Prog Clin Biol Res; 1987; 250():401-13. PubMed ID: 3423052 [No Abstract] [Full Text] [Related]
3. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin. Dale RC; Saleem MA; Daw S; Dillon MJ J Pediatr; 2000 Nov; 137(5):723-6. PubMed ID: 11060542 [TBL] [Abstract][Full Text] [Related]
4. [The mucocutaneous lymph node syndrome (Kawasaki syndrome). A case with gallbladder hydrops and coronary artery aneurysm]. Fritz ME; Giambonini S; Jenni R; D'Apuzzo V Schweiz Med Wochenschr; 1981 Apr; 111(16):566-71. PubMed ID: 7233135 [TBL] [Abstract][Full Text] [Related]
5. Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited. Hsieh KS; Weng KP; Lin CC; Huang TC; Lee CL; Huang SM Pediatrics; 2004 Dec; 114(6):e689-93. PubMed ID: 15545617 [TBL] [Abstract][Full Text] [Related]
6. Kawasaki disease: effect of treatment on coronary artery involvement. Kato H; Koike S; Yokoyama T Pediatrics; 1979 Feb; 63(2):175-9. PubMed ID: 440805 [TBL] [Abstract][Full Text] [Related]
8. [Prevention and treatment of coronary lesions in Kawasaki disease. Treatment with anti-platelet agents and aspirin: optimum dosages and their evaluation]. Shirahata A; Nakamura T; Asakura A Nihon Rinsho; 1983 Sep; 41(9):2103-10. PubMed ID: 6663747 [No Abstract] [Full Text] [Related]
11. Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin. Ichida F; Fatica NS; Engle MA; O'Loughlin JE; Klein AA; Snyder MS; Ehlers KH; Levin AR Pediatrics; 1987 Dec; 80(6):828-35. PubMed ID: 3684392 [TBL] [Abstract][Full Text] [Related]
12. Probable efficacy of high-dose salicylates in reducing coronary involvement in Kawasaki disease. Koren G; Rose V; Lavi S; Rowe R JAMA; 1985 Aug; 254(6):767-9. PubMed ID: 4009911 [TBL] [Abstract][Full Text] [Related]
13. Effect of initial corticosteroid therapy on coronary artery aneurysm formation in Kawasaki disease: a meta-analysis of 862 children. Wooditch AC; Aronoff SC Pediatrics; 2005 Oct; 116(4):989-95. PubMed ID: 16199713 [TBL] [Abstract][Full Text] [Related]
14. A trial procedure to prevent aneurysm formation of the coronary arteries by steroid pulse therapy in Kawasaki disease. Kijima Y; Kamiya T; Suzuki A; Hirose O; Manabe H Jpn Circ J; 1982 Nov; 46(11):1239-42. PubMed ID: 7131714 [TBL] [Abstract][Full Text] [Related]
15. Current recommendations for the pharmacologic therapy in Kawasaki syndrome and management of its cardiovascular complications. De Rosa G; Pardeo M; Rigante D Eur Rev Med Pharmacol Sci; 2007; 11(5):301-8. PubMed ID: 18074939 [TBL] [Abstract][Full Text] [Related]
16. Kawasaki disease: management guidelines. Nieves-Rivera F; Martin Pumarejo M; Villavicencio R Bol Asoc Med P R; 1988 Feb; 80(2):51-3. PubMed ID: 2450550 [No Abstract] [Full Text] [Related]
17. Selection of high-risk children for immunoglobulin therapy in Kawasaki disease. Iwasa M; Sugiyama K; Ando T; Nomura H; Katoh T; Wada Y Prog Clin Biol Res; 1987; 250():543-4. PubMed ID: 3423068 [No Abstract] [Full Text] [Related]
18. [Kawasaki's disease. Presentation of 2 clinical cases]. Cataldo F; Violante M; Donzelli M; Bellia L; La Monaca P Pediatr Med Chir; 1987; 9(1):99-103. PubMed ID: 3628061 [TBL] [Abstract][Full Text] [Related]
19. Can early treatment provide better prognosis in Kawasaki disease? A retrospective study on 616 children. Usami H; Harada K; Okuni M Prog Clin Biol Res; 1987; 250():577-8. PubMed ID: 3423079 [No Abstract] [Full Text] [Related]